000 01512 a2200469 4500
005 20250516080432.0
264 0 _c20120928
008 201209s 0 0 eng d
022 _a1473-5741
024 7 _a10.1097/CAD.0b013e3283512726
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFreeland, Megan M
245 0 0 _aSex differences in improved efficacy of doxorubicin chemotherapy in Cbr1+/- mice.
_h[electronic resource]
260 _bAnti-cancer drugs
_cJul 2012
300 _a584-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlcohol Oxidoreductases
_xgenetics
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xadverse effects
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aMammary Neoplasms, Animal
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Mutant Strains
650 0 4 _aMice, Transgenic
700 1 _aAngulo, Jackeline
700 1 _aDavis, Alison L
700 1 _aFlook, Adam M
700 1 _aGarcia, Brittany L
700 1 _aKing, Nathan A
700 1 _aMangibin, Samuelle K
700 1 _aPaul, Kristin M
700 1 _aProsser, Megan E
700 1 _aSata, Nicole
700 1 _aBentley, Jim L
700 1 _aOlson, Lisa E
773 0 _tAnti-cancer drugs
_gvol. 23
_gno. 6
_gp. 584-9
856 4 0 _uhttps://doi.org/10.1097/CAD.0b013e3283512726
_zAvailable from publisher's website
999 _c21553757
_d21553757